Related Experiment Video For Covid-19
Updated: Jan 17, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Primary health care response to tuberculosis treatment in Brazilian cities during the COVID-19 pandemic: a
Roxana Isabel Cardozo Gonzales1, Daiane Cardoso da Silva1, Johannes Abreu de Oliveira1
1Faculdade de Enfermagem, Universidade Federal de Goiás, Goiânia, Brazil.
Background:
The interruption of tuberculosis care and monitoring activities during the Covid-19 pandemic resulted in delays in diagnosis and treatment of this disease, which compromised progress towards the goal of elimination.
Objectives:
Analyze tuberculosis-related activities offered in primary health care settings in Brazil during 2020-2022.
Methods:
This mixed-method convergent parallel study was conducted in four state capitals, with the number of health units defined by sample calculation. Professionals in various areas were interviewed as key informants in primary care services to investigate tuberculosis-related activities provided during the pandemic. Using these findings, we identified common themes in both the quantitative and qualitative data.
Results:
Four major themes were identified: 'Consultations for people undergoing tuberculosis treatment within the context of health reorganization;' 'Compromised testing and surveillance;' 'Drug dispensing in collaborative activities to reduce the exposure of people undergoing treatment;' and 'Changes in directly observed therapy to reduce infection risk.' Changes in the tuberculosis-related activities were identified in all four cities during the study period; the mean rates of change were lowest in São Paulo and higher in Goiânia and João Pessoa for nearly all the activities offered.
Conclusions:
Structural barriers must be identified in each city (such as laboratory network function, reorganization strategies, and local and national directives) to address specific needs related to tuberculosis care during emergency situations and continue progress toward eliminating this disease.
More Related Videos
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...